Placebo-controlled trial of moclobemide in social phobia

British Journal of Psychiatry

Volumn 172, Issue JAN., 1998, Pages 70-77

  Schneier, Franklin R ^a   Goetz, Deborah ^b   Campeas, Raphael ^b   Fallon, Brian ^b   Marshall, Randall ^b   Liebowitz, Michael R ^b  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITOR; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FATIGUE; FEMALE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHOBIA; PSYCHOPHARMACOTHERAPY; SINGLE BLIND PROCEDURE; SOCIAL PHOBIA; TREATMENT OUTCOME; VERTIGO;

EID: 0031912874     PISSN: 00071250     EISSN: None     Source Type: Journal    
DOI: 10.1192/bjp.172.1.70     Document Type: Article

References (34)

1. American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders (3rd edn, revised) (DSM-III-R). Washington, DC: APA.
2. Beck, A. T., Ward, C. H., Mendelsohn, M., et al (1961) An inventory for measuring depression. Archives of General Psychiatry, 31, 319-325.
3. Bisserbe, J.-C., Lepine, J.-P. & the GRP Group (1994) Moclobemide in social phobia: a pilot open study. Clinical Neuropharmacology, 17 (suppl. 1), S88-S94.
4. Davidson, J. R. T., Potts, N., Richichi, E., et al (1993) Treatment of social phobia with clonazepam and placebo. Journal of Clinical Psychopharmacology, 13, 423-428.
5. Derogatis, L. R. (1983) SCL-90-R. Administration, Scoring, and Procedures Manual. Towson, MD: Clinical Psychometric Press.
6. Fahlen, T., Nilsson, H. L., Borg, K., et al (1995) Social phobia: the clinical efficacy and tolerability of the monoamine oxidase-A and serotonin uptake inhibitor brofaromine. Acta Psychiatrica Scandinavica, 92, 351-358.
7. Gelernter, C. S., Uhde, T. W., Cimbolic, P., et al (1991) Cognitive-behavioral and pharmacological treatments of social phobia: a controlled study. Archives of General Psychiatry, 48, 938-945.
8. Guy, W. (1976) ECDEU Assessment Manual for Psychopharmacology, pp. 217-222. Washington, DC: Department of Health, Education and Welfare Publications (ADM) 76-338.
9. Hamilton, M. (1959) The assessment of anxiety states by rating. British Journal of Medical Psychology, 32, 50-55.
10. _ (1960) A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry, 23, 56-62.
11. Heimberg, R. G., Dodge, C. S., Hope, D. A., et al (1990) Cognitive behavioral treatment of social phobia: comparison to a credible placebo control. Cognitive Therapy and Research, 14, 1-23.
12. International Multicenter Clinical Trial Group on Moclobemide in Social Phobia (1997) Moclobemide in social phobia. A double-blind, placebo controlled clinical study. European Archives of Psychiatry and Clinical Neuroscience, 24, 71-80.
13. Johnson, P. O. & Neyman, J. (1926) Tests of certain linear hypotheses and their application to some educational problems. Stat Res Memoirs, 1, 57-93.
14. Kessler, R. C., McGonagle, K. A., Zhao, A., et al (1994) Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Archives of General Psychiatry, 51, 8-19.
15. Korn, A., Da Prada, M., Raffesberg, W., et al (1988) Tyramine pressor effect in man: studies with moclobemide, a novel reversible monoamine oxidase inhibitor. Journal of Neurol Transmission, suppl. 26, 57-71.
16. Liebowitz, M. R. (1987) Social phobia. Modern Problems in Pharmacopsychiatry, 22, 141-173.
17. _, Gorman, J. M., Fyer, A. J., et al (1988) Pharmacotherapy of social phobia: an interim report of a placebo controlled comparison of phenelzine and atenolol. Journal of Clinical Psychiatry, 49, 252-257.
18. _, Schneier, F., Campeas, R., et al (1992) Phenelzine vs. atenolol in social phobia: A placebo-controlled comparison. Archives of General Psychiatry, 49, 290-300.
19. Lonnqvist, J., Sihvo, S., Syvalahti, E., et al (1993) Moclobemide and fluoxetine in atypical depression: A double-blind study. Journal of Affective Disorders, 32, 169-177.
20. Lott, M., Greist, J. H., Jefferson, J. W., et al (1997) Brofaromine for social phobia: A multicenter, placebo-controlled, double-blind study. Journal of Clinical Psychopharmacology, 17, 255-260.
21. Marks, I. M. & Matthews, A. M. (1982) Brief standard self-rating for phobic patients. Behaviour Research and Therapy, 17, 263-267.
22. Noyes, R., Moroz, G., Davidson, J. R. T., et al (1997) Moclobemide in social phobia: A controlled dose-response trial. Journal of Clinical Psychopharmacology, 17, 247-254.
23. Schneier, F. R., Heckelman, L. R., Garfinkel, R., et al (1994) Functional impairment in social phobia. Journal of Clinical Psychiatry, 55, 322-331.
24. Sheehan, D. (1983) The Anxiety Disease, pp. 148-149. New York: Scribner.
25. Spitzer, R., Williams, J. B. & Gibbon, M. (1987) Structured Clinical Interview of DSM-III-R (SCID-I). New York: Biometrics Research Department, New York Psychiatric Institute.
26. _, _, _, et al (1990) Structural Clinical Interview of DSM-III-R Axis II Disorders (SCID-II).Washington, DC: American Psychiatric Press.
27. Turner, S. M., Beidel, D. C. & Jacob, R. G. (1994) Social phobia: a comparison of behavior therapy and atenolol. Journal of Consulting and Clinical Psychology, 62, 350-358.
28. Van Vliet, I. M., den Boer, J. A. & Westenberg, H. G. M. (1992) Psychopharmacological treatment of social phobia: clinical and biochemical effects of brofaromine, a selective MAO-A inhibitor. European Neuropsychopharmacology, 2, 21-29.
29. _, _ & _ (1994) Psychopharmacological treatment of social phobia: a double-blind, placebo-controlled study with fluvoxamine. Psychopharmacology, 115, 128-134.
30. Versiani, M., Nardi, A. E., Mundim, F. D., et al (1992) Pharmacotherapy of social phobia: A controlled study with moclobemide and phenelzine. British Journal of Psychiatry, 161, 353-360.
31. _, _, _, et al (1996) The long-term treatment of social phobia with moclobemide. International Clinical Psychopharmacology, 11 (suppl. 3), 83-88.
32. Waldmeier, P. C. (1987) Amine oxidases and their endogenous substrates (with special reference to monoamine oxidase and the brain). Journal of Neural Transmission, suppl. 23, 55-72.
33. _, Glatt, A., Jaekel, J., et al (1993) Brofaromine: A monoamine oxidase-A and serotonin uptake inhibitor. Clinical Neuropharmacology, 16 (suppl. 2), S19-S24.
34. Watson, P. & Friend, R. (1969) Measurement of social-evaluative anxiety. Journal of Consulting and Clinical Psychology, 33, 448-457.